Comparison of the carbapenem inactivation method (CIM) and modified carbapenem inactivation method (mCIM) for the detection of carbapenemase-producing organisms
Amy Crowe(St Vincent's Hospital Melbourne), Mary Jo Waters(Saint Vincent Health System), Lisa Brenton(St Vincent's Hospital), Darren Jardine, Mikayla Kingston
Cited by 8
Related Papers
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
|Clinical Infectious Diseases|2020|159
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27
|Journal of Antimicrobial Chemotherapy|2017|85
Predicting functional capacity during treadmill testing independent of exercise protocol
|Medicine & Science in Sports & Exercise|1996|74
Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia
|International Journal of Antimicrobial Agents|2014|61